ArticleFrontiers in neurology
Preliminary comparison of efficacy and safety between direct bypass surgery and endovascular recanalization therapy in adult ischemic moyamoya disease.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the efficacy of endovascular recanalization therapy and direct bypass surgery in treating adult ischemic moyamoya disease. Methods: This retrospective study evaluated vascular wall conditions and occlusion characteristics preoperatively using high-resolution magnetic resonance imaging (HRMRI). Computed tomography angiography (CTA) and CT perfusion (CTP) were performed preoperatively, at 7 days, and 3 months postoperatively to assess vascular patency and cerebral perfusion. Modified Rankin Scale (mRS) scores were used to evaluate neurological function at corresponding time points. Results: A total of 67 adult patients with ischemic moyamoya disease were included, comprising 43 patients undergoing direct bypass surgery (bypass group) and 24 receiving endovascular recanalization therapy (endovascular group). Intraoperative indocyanine green angiography confirmed successful anastomosis or recanalization in all patients. Postoperative imaging showed no cerebral hemorrhage or acute infarction. Both groups demonstrated significant improvements in cerebral perfusion parameters compared to baseline ( Conclusion: In this preliminary study, endovascular recanalization therapy was feasible and demonstrated promising short-term outcomes, showing comparable improvements in cerebral perfusion and neurological function to direct bypass surgery at 3-month follow-up. However, the long-term durability, restenosis rates, and clinical implications of this finding require further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.